AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $432,000 | +22.7% | 45,906 | -0.3% | 0.00% | – |
| Q2 2020 | $352,000 | +13.9% | 46,022 | -8.0% | 0.00% | – |
| Q1 2020 | $309,000 | -25.2% | 50,031 | +47.5% | 0.00% | – |
| Q4 2019 | $413,000 | +9.8% | 33,921 | +4.1% | 0.00% | – |
| Q3 2019 | $376,000 | +196.1% | 32,586 | +157.3% | 0.00% | – |
| Q2 2019 | $127,000 | -21.6% | 12,663 | +0.8% | 0.00% | – |
| Q1 2019 | $162,000 | -97.7% | 12,563 | -97.3% | 0.00% | -100.0% |
| Q4 2018 | $7,019,000 | -25.0% | 462,106 | -1.3% | 0.00% | 0.0% |
| Q3 2018 | $9,364,000 | +3.6% | 468,182 | +1.0% | 0.00% | 0.0% |
| Q2 2018 | $9,041,000 | +67.8% | 463,661 | +73.4% | 0.00% | 0.0% |
| Q1 2018 | $5,388,000 | +105.2% | 267,412 | +34.9% | 0.00% | – |
| Q4 2017 | $2,626,000 | -27.6% | 198,159 | +0.8% | 0.00% | -100.0% |
| Q3 2017 | $3,627,000 | -4.7% | 196,586 | -4.9% | 0.00% | 0.0% |
| Q2 2017 | $3,806,000 | -22.8% | 206,822 | -5.4% | 0.00% | 0.0% |
| Q1 2017 | $4,932,000 | -33.0% | 218,720 | +3.4% | 0.00% | 0.0% |
| Q4 2016 | $7,360,000 | +48.5% | 211,500 | +4.6% | 0.00% | 0.0% |
| Q3 2016 | $4,956,000 | -61.2% | 202,190 | -62.1% | 0.00% | -66.7% |
| Q2 2016 | $12,761,000 | +4.8% | 533,500 | +2.5% | 0.00% | 0.0% |
| Q1 2016 | $12,177,000 | -24.0% | 520,380 | -1.9% | 0.00% | 0.0% |
| Q4 2015 | $16,012,000 | -20.6% | 530,360 | +4.5% | 0.00% | -25.0% |
| Q3 2015 | $20,165,000 | -37.1% | 507,560 | +9.3% | 0.00% | -42.9% |
| Q2 2015 | $32,076,000 | +34.2% | 464,470 | +6.2% | 0.01% | +40.0% |
| Q1 2015 | $23,901,000 | +29.5% | 437,270 | +1.0% | 0.01% | +25.0% |
| Q4 2014 | $18,453,000 | +35.7% | 432,970 | +1.6% | 0.00% | +33.3% |
| Q3 2014 | $13,597,000 | +54.3% | 426,120 | +0.2% | 0.00% | +50.0% |
| Q2 2014 | $8,811,000 | -68.0% | 425,220 | -70.1% | 0.00% | -66.7% |
| Q1 2014 | $27,499,000 | -65.8% | 1,421,120 | -57.1% | 0.01% | -33.3% |
| Q4 2013 | $80,334,000 | +78.2% | 3,310,040 | +57.7% | 0.01% | -18.2% |
| Q3 2013 | $45,093,000 | -50.3% | 2,099,322 | -48.5% | 0.01% | -8.3% |
| Q2 2013 | $90,754,000 | – | 4,078,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $14 | 0.00% |